VDI
DGX icon

Vaughan David Investments’s Quest Diagnostics DGX Stock Holding History

Vaughan David Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,385
Closed -$686K – 199
2022
Q4 		$686K Sell
4,385
-795
-15% -$114K 0.02% 135
2022
Q3 		$636K Sell
5,180
-235
-4% -$30.9K 0.02% 139
2022
Q2 		$720K Sell
5,415
-3,310
-38% -$451K 0.02% 133
2022
Q1 		$1.19M Sell
8,725
-59,402
-87% -$8.28M 0.04% 122
2021
Q4 		$11.8M Sell
68,127
-12,130
-15% -$1.85M 0.34% 87
2021
Q3 		$11.7M Sell
80,257
-165,507
-67% -$24.2M 0.37% 85
2021
Q2 		$32.4M Buy
245,764
+4,672
+2% +$612K 1.01% 44
2021
Q1 		$30.9M Buy
241,092
+390
+0.2% +$48.1K 0.98% 42
2020
Q4 		$28.7M Buy
240,702
+1,034
+0.4% +$126K 0.98% 43
2020
Q3 		$27.4M Buy
239,668
+700
+0.3% +$82.7K 1.06% 36
2020
Q2 		$27.2M Buy
238,968
+4,223
+2% +$448K 1.11% 34
2020
Q1 		$18.9M Buy
234,745
+5,275
+2% +$546K 0.88% 52
2019
Q4 		$24.5M Buy
229,470
+7,010
+3% +$731K 0.9% 60
2019
Q3 		$23.8M Buy
+222,460
New +$22.8M 0.91% 57

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vaughan David Investments's DGX Position: Q1 2023 in Review

Vaughan David Investments sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 4,385 shares — an estimated $686K sold.

Vaughan David Investments first reported a position in DGX in Q3 2019 and held it in 14 quarters. The position peaked at $32.4M in Q2 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Vaughan David Investments reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Vaughan David Investments sold 4,385 Quest Diagnostics shares in Q1 2023, an estimated $686K.
  • Vaughan David Investments first reported a position in Quest Diagnostics in Q3 2019 and held it in 14 quarters.
  • Vaughan David Investments's Quest Diagnostics position peaked at $32.4M in Q2 2021.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Vaughan David Investments's 13F filing for Q1 2023, filed 2 May 2023.